mRNA– tag –
-
PackGene Biotech Accelerates Next-Gen CAR-T Development with Lentiviral and mRNA Technologies
PackGene Biotech China Overview PackGene Biotech is advancing next-generation CAR-T cell development by offering both lentiviral vector (LVV) and mRNA technologies for manufacturing. LVVs are a core technology enabling stable, long-term ... -
Diversa Technologies Develops Biodegradable Lipid Nanoparticle Platform for Protein Replacement Therapy, Accelerating Next-Gen Therapeutic Development
Diversa Technologies USA Overview Diversa Technologies is developing advanced nanomedicine platforms based on biodegradable lipid nanoparticles for targeted and controlled delivery of therapeutic modalities like mRNA and proteins, accele... -
OZ Biosciences Develops ‘NanOZ-LNP Stem’ mRNA Delivery System for Stem Cells: Achieves Over 90% Transfection Efficiency and Cell Viability Preservation
OZ Biosciences France Overview OZ Biosciences has developed NanOZ-LNP Stem, a proprietary lipid formulation optimized for efficient mRNA delivery to stem cells. This LNP system protects mRNA, facilitates intracellular uptake, and importa... -
MDPI Review Highlights Lipid Nanoparticles (LNPs) as Key to Rapid Antiviral Strategies for Pandemic Preparedness
MDPI International Overview A new MDPI review elaborates on nanoparticle-mediated antiviral strategies, emphasizing lipid nanoparticle (LNP) systems for their rapid response and efficient nucleic acid delivery in pandemic preparedness. N... -
Exosome Clinical Trials Hit ~90 Globally in 2026: Advancing Regenerative Medicine, Diagnostic Biomarkers, and Drug Delivery
OmniGenix USA Overview A new peer-reviewed analysis in 2026 reveals approximately 90 exosome-related human clinical trials registered globally, showcasing diverse applications from cancer diagnostics to joint repair. Exosomes are being i... -
Albumin-Hitchhiking Lipid Nanoparticles Achieve 80% Liver Accumulation Reduction and 2-3x Lymphatic mRNA Expression
ACS Materials Au USA Overview A novel lipid nanoparticle (LNP) delivery concept has been developed to overcome the off-target liver accumulation and associated hepatotoxicity of mRNA therapeutics by interacting with endogenous albumin. T... -
Cytiva Advances In Vivo CAR-T Therapy with Targeted mRNA-LNP Delivery to the Spleen
Cytiva スウェーデン Overview Cytiva is making significant strides in *in vivo* CAR-T therapy by utilizing advanced lipid nanoparticle (LNP) systems for direct T cell reprogramming within patients. This innovative approach extends LNP del... -
Labcorp Strengthens Lipid Nanoparticle (LNP) Development as Non-Viral Vectors for Vaccine and Cell/Gene Therapy
Labcorp USA Overview Labcorp is emphasizing the crucial role of lipid nanoparticles (LNPs) as effective non-viral vectors for nucleic acid delivery in vaccines, cancer therapies, and cell and gene therapies. A key industry challenge is d... -
Taylor & Francis Unveils Advanced Nanomedicine Strategies Revolutionizing Precision Therapeutics via Bioresponsive Materials, Lipid Nanoparticles, and Metal Nanostructures
Taylor & Francis Online (Article Collection) UK Overview Taylor & Francis has published an article collection highlighting advanced nanomedicine strategies that offer unprecedented control over pharmaceutical agent delivery, revoluti... -
Samsung Biologics Expands Bio R&D Center Beyond CDMO Support, Investing in Next-Gen Modalities, AI, and Machine Learning
Korea Biomedical Review (KBR) South Korea Overview Samsung Biologics is significantly expanding its Bio R&D Center beyond traditional Contract Development and Manufacturing Organization (CDMO) support. The company is focusing on thre...
